Therapeutic Advances in Neurological Disorders
- Launched in 2008.
- Gold open access journal – all articles are made freely available online immediately upon publication.
- Rigorous peer review.
- Listed in PubMed Central and indexed in Web of Science, Science Citation Index Expanded (SCIE) and Scopus.
- A leading gold open access in clinical neurology.
- Over 400k full-text article views annually.
This journal flipped to open access on September 1, 2016.
Diversity, Equity and Inclusion Statement
Therapeutic Advances in Neurological Disorders promotes inclusive, open science that reflects the disciplinary, human, and geographic diversity of the neurology community.
Diversity as a core value embodies inclusiveness, mutual respect, and multiple perspectives.
We welcome editors, editorial board members, peer reviewers and authors from all backgrounds, cultures, ethnicities, nationalities, races, religions, sexes, sexual orientations, gender identities, mental or physical (dis)abilities, ages, career stages, socioeconomic status or any other individual status.
We are committed to continually improving our editorial and review processes whilst playing our part in eradicating bias and inequality in all forms.
Submission information
Please see the Submission Guidelines tab for more information on how to submit your article to the journal.
Open access article processing charge (APC) information
Unsolicited manuscripts submitted to Therapeutic Advances in Neurological Disorders are subject to an Article Processing Charge (APC) of 2650 USD (+VAT where applicable) payable upon acceptance.The article processing charge for Plain Language Summary is 4500 USD. These articles will be published under a Creative Commons licence and will be made openly available.
The article processing charge (APC) is payable when a manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Please see further details here.
Contact
Please direct any queries to neuro@sagepub.co.uk.
Therapeutic Advances in Neurological Disorders delivers the highest quality peer-reviewed original research articles, reviews, and scholarly comment on pioneering efforts and innovative studies in the medical treatment of neurological conditions. The journal has a strong clinical and pharmacological focus and is aimed at an international audience of clinicians and researchers in neurology and related disciplines, providing an online forum for rapid dissemination of recent research and perspectives in this area.
The editors welcome original research articles across all areas of neurology.
The journal is dedicated to publishing clinical research. We do not publish preclinical research, including basic laboratory research and animal studies.
Review articles include expert opinion/perspective reviews (including single-drug and drug class reviews), narrative reviews and therapeutic area reviews. Systematic reviews, meta-analyses, postmarketing and health economic and pharmacoeconomic reviews are also welcomed. The appropriate EQUATOR Network reporting guidelines should be followed (e.g. CONSORT for randomized, controlled trials and PRISMA for systematic reviews/meta-analyses). The journal endorses the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment. The trial registry name and URL, and registration number must be included at the end of the abstract.
The journal adheres to a single-blind review process in which the reviewer's name is routinely withheld from the author unless the reviewer requests a preference for their identity to be revealed. Manuscripts are reviewed by at least two referees.
| Professor Ralf Gold, MD | Dept of Neurology, Ruhr University Bochum, Bochum, Germany |
| Professor Marinos C Dalakas, MD | Thomas Jefferson University, Philadelphia, PA, USA |
| Professor Albert Ludolph, MD | RKU - Universitäts- und Rehabilitationskliniken, Ulm, Germany |
| Professor Olaf Stuve, MD, PhD | University of Texas Southwestern Medical Center, Dallas, TX, USA |
| Professor Georgios Tsivgoulis, MD, PhD, MSc, FESO, FEAN, FAAN | Second Dept of Neurology, National & Kapodistrian University of Athens, Athens, Greece |
| Professor Matthew Walker, MA, MB, Bchir, PhD, FRCP | University College London, London, UK |
| Hemi Malkki, PhD | SAGE Publishing, London, UK |
| Joshua Gazmin | SAGE Publishing, London, UK |
| Lingling Tian, PhD | SAGE Publishing, Shanghai, China |
| Pramila Gawali | SAGE Publishing, India |
| Praveen Anand, MD | Imperial College London, London, UK |
| Professor Corrado Angelini, MD, PhD | University of Padova, Padova, Italy |
| Professor Melissa Armstrong, MD, MSc, FAAN | University of Florida, Gaineswille, FL, USA |
| Professor Kailash Bhatia, MD | University College London, London, UK |
| Professor Stéphanie Debette, MD, PhD | Bordeaux University Hospital, Bordeaux, France |
| Professor Hans-Christoph Diener, MD, PhD | University Essen, Essen, Germany |
| Professor Peter Goadsby, MBBS, MD, PhD, DSc, FRACP, FRCP | King's College, London, UK |
| Professor Hans-Peter Hartung, MD, PhD, FRCP | Heinrich-Heine University, Düsseldorf, Germany |
| Professor Ryuji Kaji, MD, PhD | Tokushima University Graduate School of Medicine, Tokushima, Japan |
| Professor Michael Kaplitt, MD, PhD | Weill Medical College of Cornell University, New York, NY, USA |
| Professor Trevor Kilpatrick, MBBS PhD FRACP | University of Melbourne, Melbourne, Australia |
| Professor Liping Liu, MD, PhD | Beijing Tiantan Hospital, Capital Medical University, Beijing, China |
| Professor Xavier Montalban, M.D., PhD, FAAN, FEAN, FCAHS | Vall d'Hebron University Hospital, Barcelona, Spain |
| Dr. Ichizo Nishino, MD, PhD | National Center of Neurology and Psychiatry, Tokyo, Japan |
| Professor Michael Platten, MD | German Cancer Research Center, Universität Heidelberg, Heidelberg, Germany |
| Professor Felix Rosenow, MD | Universitätsklinikum Frankfurt, Frankfurt am Main, Germany |
| Professor Uwe Schlegel, MD | University Hospital Knappschaftskrankenhaus, Ruhr-University Bochum, Bochum, Germany |
| Dr. Graeme Sills, PhD | University of Glasgow, Glasgow, UK |
| Professor Per Soelberg Sørensen, MD, DMSc, FAAN | Copenhagen University Hospital, Copenhagen, Denmark |
| Professor Maria Pia Sormani, PhD | University of Genoa, Genoa, Italy |
| Professor Turgut Tatlisumak, MD, PhD | University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden |
| Professor Klaus V Toyka, MD, FRCP | Universität Würzburg, Würzburg, Germany |
| Professor Eugen Trinka, MD, MSC, FRCP | Neuroscience Institute, Christian-Doppler University Hospital, Paracelsus Medical University, Salzburg, Austria |
| Professor Shuang Wang, MD, PhD | Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China Hangzhou, China |
| Professor Patrick Wen, MD | Dana-Farber Cancer Institute, Brigham and Women's Hospital Boston, MA, United States |
| Professor Jo Wilmshurst, MB BS, MRCPaed, FCPaed, MD | Red Cross War Memorial Children's Hospital, University of Cape Town, South Africa |
| Professor Adrian Wong, BSc, MSocSc Clinical Psychology, PhD, AFHKPS | The Chinese University of Hong Kong, Hong Kong, China |
| Professor Xuejun Yang, MD, PhD | Tianjin Medical University General Hospital, Beijing Tsinghua Changgung Hospital, China |
| Professor Cuantao Zuo, MD, PhD | Fudan University, Shanghai, China |
Manuscript submission guidelines can be accessed on Sage Journals.